Harvest Fund Management Co. Ltd raised its holdings in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 9.8% in the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 26,150 shares of the semiconductor company’s stock after buying an additional 2,340 shares during the quarter. Harvest Fund Management Co. Ltd’s holdings in Synopsys were worth $12,903,000 at the end of the most recent reporting period.
A number of other institutional investors also recently bought and sold shares of the stock. Prudential PLC grew its stake in shares of Synopsys by 61.0% during the 3rd quarter. Prudential PLC now owns 19,157 shares of the semiconductor company’s stock worth $9,452,000 after purchasing an additional 7,259 shares during the period. Aspex Management HK Ltd increased its holdings in shares of Synopsys by 135.0% during the 3rd quarter. Aspex Management HK Ltd now owns 1,517,582 shares of the semiconductor company’s stock valued at $748,760,000 after purchasing an additional 871,687 shares in the last quarter. Comerica Bank lifted its stake in shares of Synopsys by 10.9% in the 3rd quarter. Comerica Bank now owns 33,771 shares of the semiconductor company’s stock valued at $16,662,000 after purchasing an additional 3,317 shares during the period. Nicolet Bankshares Inc. purchased a new stake in Synopsys during the third quarter worth $238,000. Finally, Newbridge Financial Services Group Inc. boosted its holdings in Synopsys by 460.0% during the third quarter. Newbridge Financial Services Group Inc. now owns 588 shares of the semiconductor company’s stock worth $290,000 after buying an additional 483 shares in the last quarter. 85.47% of the stock is currently owned by institutional investors and hedge funds.
Synopsys Stock Performance
NASDAQ SNPS opened at $412.63 on Friday. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $651.73. The firm has a market capitalization of $79.04 billion, a P/E ratio of 64.07, a price-to-earnings-growth ratio of 3.41 and a beta of 1.15. The stock’s fifty day moving average is $461.93 and its two-hundred day moving average is $464.57. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.26 and a current ratio of 1.36.
Insider Activity at Synopsys
In other news, CFO Shelagh Glaser sold 3,657 shares of Synopsys stock in a transaction on Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the sale, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. The trade was a 17.01% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Janet Lee sold 250 shares of the business’s stock in a transaction on Monday, January 12th. The shares were sold at an average price of $530.00, for a total value of $132,500.00. Following the completion of the sale, the insider owned 11,959 shares in the company, valued at $6,338,270. This represents a 2.05% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 4,157 shares of company stock worth $1,945,036. Company insiders own 0.56% of the company’s stock.
Wall Street Analysts Forecast Growth
SNPS has been the subject of several recent analyst reports. Morgan Stanley reissued an “equal weight” rating and issued a $480.00 price target (down from $550.00) on shares of Synopsys in a research note on Wednesday, February 25th. Weiss Ratings restated a “hold (c)” rating on shares of Synopsys in a research report on Thursday, January 22nd. Citigroup began coverage on shares of Synopsys in a research report on Monday, November 24th. They issued a “buy” rating and a $580.00 target price on the stock. Bank of America raised shares of Synopsys from an “underperform” rating to a “neutral” rating and cut their target price for the stock from $525.00 to $500.00 in a research note on Monday, December 8th. Finally, HSBC downgraded shares of Synopsys from a “buy” rating to a “hold” rating and set a $455.00 price target for the company. in a research report on Friday, February 20th. Eight analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $531.00.
Check Out Our Latest Report on Synopsys
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Recommended Stories
- Five stocks we like better than Synopsys
- A personal warning from Martin Weiss (Please read)
- SpaceX IPO Confirmed: Claim Your Stake Today
- Iran isn’t the real war
- This coin has everything going for it
- Only 500 people today…
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
